Literature DB >> 2783324

Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo.

N Lycke1, A K Bromander, L Ekman, U Karlsson, J Holmgren.   

Abstract

Cholera toxin (CT) is a potent oral immunogen that also acts as a strong mucosal adjuvant for immune responses to related as well as unrelated Ag. To elucidate the immunomodulating effects of CT at the cellular level we have examined interactions of CT with APC and with B and T lymphocytes in vitro. CT markedly stimulated the production of IL-1 from APC (mouse peritoneal macrophages or macrophage cell line P388D1) but did not induce Ia-Ag and had marginal, if any, effect in potentiating Ia Ag expression stimulated by rIFN-gamma on these cells. CT had differential effect on T cell proliferation in vitro, usually strongly inhibitory but on Con A-stimulated spleen cells during prolonged (greater than or equal to 5 days) culture or when added on day 4 or later to these cultures up to a two- to three-fold enhancement of proliferation was seen. CT-induced inhibition of T cell proliferation was associated with decreased production of IL-2 and anergy to exogenously added IL-2 despite apparently normal expression of IL-2R. Similar to what was found with T cells LPS-stimulated spleen B cells demonstrated both inhibition and enhancement of proliferation in the presence of CT: in high concentrations (greater than or equal to 10(-8) M) and early in culture (day 3) CT had a strong inhibitory effect on the proliferation of B cells, whereas later (day 6) and/or at lower CT concentrations (10(-9) to 10(-11) M) the proliferation was increased up to 10-fold. The net effect of CT treatment on Ig-production by LPS-stimulated spleen B cells was seen as an enhanced level of IgA and IgG but not IgM in culture supernatants. The differential effects of CT on the cells of the immune system observed in vitro may, singly or in combination, explain the immunostimulatory function of CT.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783324

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Activation of cholera toxin-specific T cells in vitro.

Authors:  C O Elson; S Solomon
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and lps genes.

Authors:  C O Elson
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

Review 3.  Molecular effects of cholera toxin on isotype differentiation.

Authors:  N Lycke; E Severinson; W Strober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.

Authors:  R J Jackson; K Fujihashi; J Xu-Amano; H Kiyono; C O Elson; J R McGhee
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

6.  Differential regulation of macrophage interleukin-1 (IL-1), IL-12, and CD80-CD86 by two bacterial toxins.

Authors:  D L Foss; M J Zilliox; M P Murtaugh
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue.

Authors:  A Porgador; H F Staats; Y Itoh; B L Kelsall
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines.

Authors:  D W McGee; C O Elson; J R McGhee
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.

Authors:  J C Bowen; S K Nair; R Reddy; B T Rouse
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

10.  Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease.

Authors:  A Tarkowski; H Carlsten; H Herlitz; G Westberg
Journal:  Agents Actions       Date:  1990-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.